Parkinson's disease: progression and mortality in the L-DOPA era

Adv Neurol. 1996;69:3-11.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Antiparkinson Agents / adverse effects
  • Antiparkinson Agents / therapeutic use*
  • Cause of Death
  • Dementia / complications
  • Disease Progression
  • Dyskinesia, Drug-Induced / complications
  • Dyskinesia, Drug-Induced / epidemiology
  • Dyskinesia, Drug-Induced / physiopathology
  • Female
  • Follow-Up Studies
  • Humans
  • Hypotension, Orthostatic / complications
  • Hypotension, Orthostatic / physiopathology
  • Levodopa / adverse effects
  • Levodopa / therapeutic use*
  • Life Expectancy
  • Male
  • Middle Aged
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / mortality*
  • Parkinson Disease / physiopathology
  • Survival Analysis

Substances

  • Antiparkinson Agents
  • Levodopa